Metaplastic breast cancer: the role of molecular subtype in prognosis

The molecular subtype was not associated with the prognosis. In addition, patients could not benefit from CT. In contrast, RT might be associated with improved survival both OS and BCSS in TN MBC and HRp MBC but not HER2-positive patients. Those results will help to reduce the part of patients’ health hazards of x-ray radiation.分子亚型与患者预后无显著关联。此外，患者无法从计算机断层扫描（CT）治疗中获益。与之相对，放射治疗（RT）或可提升三阴性转移性乳腺癌（TN MBC）与激素受体阳性转移性乳腺癌（HRp MBC）患者的总生存期（OS）及乳腺癌特异性生存期（BCSS），但对人表皮生长因子受体2阳性（HER2-positive）患者无此获益。本研究结果将有助于减轻X射线辐射（X-ray radiation）给患者带来的部分健康危害。